Viatris stock price at $11.28 remains resilient despite sector headwinds, supported by stable cash flow and sustained dividend yield of around 4.5%. Amneal scored the biggest analyst estimates beat and fastest revenue growth, but had the weakest full-year guidance update among its peers. The stock is down 7% since reporting and currently trades at $8. The Zacks Consensus Estimate for revenues from Developed Markets is pinned at $2.1 billion. The current Viatris stock price sits near $11.30, supported by a 50-day moving average trendline, suggesting near-term consolidation. Market sentiment remains neutral, with options traders pricing limited volatility over the next two weeks.